The management of heart failure: a FADOI survey in the setting of Internal Medicine Units
Abstract
Heart failure (HF) is a chronic disease characterized by high morbidity and mortality. FADOI conducted a survey aimed at obtaining information on the management of HF in Italy, with particular reference to the Internal Medicine (IM) Units. The questionnaire, containing 32 questions, was sent to the Directors. Up to August 2022, it was possible to analyze data from140 centers. In 47.4±17.2% of cases with HF, the patients have preserved systolic function; 41% are in NYHA class III, 33% in class IV (33%), 21% and 5% in NYHA class II and I, respectively. The mean length of hospital stay is 9±2.5 days, with an inhospital mortality of 11.9%±9.5%. After discharge, the re-hospitalizations are 21.3±12.7%. In 44.4% of IM departments, there is a formal diagnostic-therapeutic care pathway. Also, through surveys, it is possible to help hospitals to and optimize assistance to patients affected by HF.
Keywords
References
- McDonagh T, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021:1-128.
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145:e895-1032. DOI: https://doi.org/10.1161/CIR.0000000000001073
- Gnerre P, Di Pasquale G (guest editors). Lo scompenso cardiaco a 360 gradi. Quad Ital J Med 2021;9(2). DOI: https://doi.org/10.4081/itjm.q.2021.2
- Gallucci F, Coppola MG, Ciarambino T, et al. A FADOI survey on heart failure management in Campanian Internal Medicine Wards. Health Sci J 2021;15:36.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.